CLEARWATER, FL – May 04, 2016 – Bovie Medical Corporation (“Bovie” or the “Company”) (NYSE: BVX), a maker of medical devices and supplies and the developer of J-Plasma^®, a patented new surgical product, announced today that Robert L. Gershon, Chief Executive Officer of the Company, and Jay Ewers, Chief Financial Officer, will participate in the Drexel Hamilton Micro Cap Investor Forum on May 12, 2016.

The forum will be held at the Drexel Hamilton offices in New York. Mr. Gershon and Mr. Ewers will present at 1:00pm. Investors attending may arrange a one-on-one meeting by contacting Drexel Hamilton.

About Bovie Medical Corporation

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma® utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website www.boviemed.com.